Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.85K Sell
231
-9
-4% -$402 0.01% 771
2026
Q1
$11.6K Sell
240
-2
-0.8% -$93 0.01% 630
2025
Q4
$11.7K Sell
242
-14
-5% -$694 0.01% 656
2025
Q3
$12.1K Buy
256
+15
+6% +$724 0.01% 641
2025
Q2
$11.6K Buy
241
+14
+6% +$715 0.01% 619
2025
Q1
$12.6K Sell
227
-279
-55% -$15.1K 0.01% 585
2024
Q4
$24.4K Buy
+506
New +$25.7K 0.02% 425

Other funds holding SNY

WPG Advisers's SNY Position: Q2 2026 in Review

WPG Advisers reduced its Sanofi (SNY) stake by 3.8% in Q2 2026, selling an estimated $402 and leaving 231 shares worth $9.85K. The position accounts for 0.01% of the portfolio, ranked #771.

WPG Advisers first reported a position in SNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $24.4K in Q4 2024. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • WPG Advisers held 231 shares of Sanofi worth $9.85K as of Q2 2026.
  • WPG Advisers sold 9 Sanofi shares in Q2 2026, an estimated $402.
  • Sanofi made up 0.01% of WPG Advisers's portfolio in Q2 2026, its #771 holding.
  • WPG Advisers first reported a position in Sanofi in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Sanofi position peaked at $24.4K in Q4 2024.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.